Glaukos® iStent Infinite Trabecular Micro-Bypass System in Subjects With Mild to Moderate
Prospective, multicenter, single-arm study of the iStent infinite in adult pseudophakic or phakic subjects with mild to moderate primary open angle glaucoma who have not failed conventional medical and surgical treatment
| Condition(s) | Glaucoma |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | Prospective, multicenter, single-arm study of the iStent infinite in adult pseudophakic or phakic subjects with mild to moderate primary open angle glaucoma who have not failed conventional medical and surgical treatment |
| Who can participate | Inclusion Criteria: * Diagnosis of primary open-angle glaucoma * Phakic or pseudophakic * Age 35 years or older Exclusion Criteria: * Traumatic, uveitic, neovascular, angle-closure glaucoma or * glaucoma associated with vascular disorders * Active corneal inflammation or edema * Retinal disorders not associated with glaucoma |
| Ages | 35 Years |
| Sex | All |
| Lead sponsor | Glaukos Corporation |
| Locations | Cincinnati, Ohio, United States |
| Start date | 2023-09-01 |
| NCT ID | NCT06057051 |
| Official listing | https://clinicaltrials.gov/study/NCT06057051 |